Affiliation
Center for Innovation in Brain Science, University of ArizonaIssue Date
2021Keywords
AccuracyClassification
Deep neural network (DNN)
Feature
Magnetic resonance imaging (MRI)
Support vector machine (SVM)
Metadata
Show full item recordPublisher
Tech Science PressCitation
G. S. Suri, G. Kaur and S. Moein, "Machine learning in detecting schizophrenia: an overview," Intelligent Automation & Soft Computing, vol. 27, no.3, pp. 723–735, 2021.Rights
This work is licensed under a Creative Commons Attribution 4.0 International License. Copyright is held by the author(s) or the publisher. If your intended use exceeds the permitted uses specified by the license, contact the publisher for more information.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Schizophrenia (SZ) is a mental heterogeneous psychiatric disorder with unknown cause. Neuroscientists postulate that it is related to brain networks. Recently, scientists applied machine learning (ML) and artificial intelligence for the detection, monitoring, and prognosis of a range of diseases, including SZ, because these techniques show a high performance in discovering an association between disease symptoms and disease. Regions of the brain have significant connections to the symptoms of SZ. ML has the power to detect these associations. ML interests researchers because of its ability to reduce the number of input features when the data are high dimensional. In this paper, an overview of ML models for detecting SZ disorder is provided. Studies are presented that applied magnetic resonance imaging data and physiological signals as input data. ML is utilized to extract significant features for predicting and monitoring SZ. Reviewing a large number of studies shows that a support vector machine, deep neural network, and random forest predict SZ with a high accuracy of 70%–90%. Finally, the collected results show that ML methods provide reliable answers for clinicians when making decisions about SZ patients. © 2021 Mark A. Lemley & Bryan Casey.Note
Open access journalISSN
1079-8587Version
Final published versionae974a485f413a2113503eed53cd6c53
10.32604/IASC.2021.015049
Scopus Count
Collections
Except where otherwise noted, this item's license is described as This work is licensed under a Creative Commons Attribution 4.0 International License. Copyright is held by the author(s) or the publisher. If your intended use exceeds the permitted uses specified by the license, contact the publisher for more information.
